Jump Financial’s BridgeBio Pharma BBIO Stock Holding History

Jump Financial’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07M	Buy	41,156 +20,556	+100%	+$1.44M	0.02%	717
2026 Q1	$1.53M	Buy	+20,600	New	+$1.49M	0.02%	763
2023 Q3	–	Sell	-12,703	Closed	-$218K	–	1850
2023 Q2	$218K	Buy	+12,703	New	+$191K	0.01%	1483
2022 Q4	–	Sell	-94,996	Closed	-$944K	–	1573
2022 Q3	$944K	Buy	+94,996	New	+$987K	0.04%	646
2022 Q2	–	Sell	-152,696	Closed	-$1.55M	–	1616
2022 Q1	$1.55M	Buy	+152,696	New	+$1.57M	0.07%	357
2021 Q4	–	Sell	-15,006	Closed	-$703K	–	1380
2021 Q3	$703K	Buy	+15,006	New	+$804K	0.05%	384
2021 Q1	–	Sell	-18,000	Closed	-$1.28M	–	945
2020 Q4	$1.28M	Buy	18,000 +6,312	+54%	+$305K	0.22%	105
2020 Q3	$439K	Buy	+11,688	New	+$368K	0.09%	371

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Jump Financial's BBIO Position: Q2 2026 in Review

Jump Financial increased its BridgeBio Pharma (BBIO) stake by 100% in Q2 2026, buying an estimated $1.44M and bringing the position to 41,156 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #717.

Jump Financial first reported a position in BBIO in Q3 2020 and has held it in 8 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Jump Financial held 41,156 shares of BridgeBio Pharma worth $3.07M as of Q2 2026.
Jump Financial bought 20,556 BridgeBio Pharma shares in Q2 2026, an estimated $1.44M.
BridgeBio Pharma made up 0.02% of Jump Financial's portfolio in Q2 2026, its #717 holding.
Jump Financial first reported a position in BridgeBio Pharma in Q3 2020 and has held it in 8 quarters since.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.